This section explores the use of NPs to target necroptosis for the treatment of DKD, mainly involving RIPK3 and MLKL protein expression, the effects of pyroptosis and autophagy crosstalk under the influence of NPs. The gene discussed is MLKL; the disease is diabetic kidney disease.